Types of Cancer We Treat

Liver & Bile Duct Cancers

We provide innovative, evidence-based treatments for people with liver tumors, cancer that has spread to the liver from other organs, such as the colon, and bile duct cancer. Your team of experts includes hepatologists, who specialize in liver diseases, as well as medical oncologists, oncologic surgeons, interventional radiologists, nurses, social workers, and rehabilitation and palliative medicine specialists.

We create a personalized plan and offer modern diagnostic tools and advanced treatments, including specialized procedures performed before surgery to improve liver function. What’s more, we are home to one of the area’s premier centers for liver transplantation.

Meet Our Doctors
Dr. Ted Welling
Diagnosis
Diagnosing Liver and Bile Duct Cancers
Surgery
Surgery for Liver and Bile Duct Cancers
Liver Transplantation
Liver Transplantation for Liver and Bile Duct Cancers
Ablation Therapies
Ablation Therapies for Liver and Bile Duct Cancers
Embolization
Embolization for Liver and Bile Duct Cancers
Targeted Drugs
Targeted Drugs for Liver and Bile Duct Cancers

Related News

Renowned Specialists to Lead Liver Disease Programs
Read Story

Clinical Trials and Research Studies

Phase 3

A Phase 3 Randomized Double-blind Study of Adjuvant Nivolumab versus Placebo for Participants with Hepatocellular Carcinoma Who Are at High Risk of Recurrence after Curative Hepatic Resection or Ablation

Phase N/A

RadioEmbolization for the ADvancement of Y90 Glass Microspheres Registry for patients with liver cancer (READY90)

Phase 3

A PHASE III OPEN-LABEL RANDOMIZED STUDY OF ATEZOLIZUMAB IN COMBINATION WITH BEVACIZUMAB COMPARED WITH SORAFENIB IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC HEPATOCELLULAR CARCINOMA

Phase 1

A Phase 1 First-in-Human Open Label Dose Escalation Study of MGD009 A Humanized B7-H3 x CD3 Dual-Affinity Re-Targeting (DART ) Protein in Patients with Unresectable or Metastatic B7-H3-Expressing Neoplasms and Neoplasms whose Vasculature Expresses